Effect of Motor Imagery With Virtual Reality in Patients With Stroke
Launched by ABANT IZZET BAYSAL UNIVERSITY · Dec 30, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how virtual reality (VR) can help patients who have had a stroke improve their recovery. The idea is that not only can doing movements help, but even imagining those movements can promote healing in the brain. The researchers are currently looking for participants to join the study, which is open to all genders, and they should be between the ages of 65 and 74 or 29 and 219 days post-stroke.
To be eligible, participants must have been diagnosed with a stroke, be able to speak, read, and write in Turkish, and have certain levels of hand function. They also need to have a good score on a simple mental test to ensure they can understand the study. However, people with other serious neurological or orthopedic issues, those who experience severe motion sickness, or individuals who ignore the affected side of their body cannot participate. If you join the trial, you can expect to engage with virtual reality exercises that may help improve your motor skills and overall recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed as stroke patient.
- • Speaks, reads and writes in Turkish.
- • Hand functions at 4, 5, 6 levels according to Brunnstrom.
- • Mini mental test score to be at least 24.
- • Volunteer for participation.
- Exclusion Criteria:
- • Neurological, orthopedic problems other than stroke.
- • To have motion sickness that cannot continue 3D application.
- • Individuals neglecting the affected side
About Abant Izzet Baysal University
Abant Izzet Baysal University is a prominent academic institution located in Turkey, dedicated to advancing education, research, and innovation in various fields, including healthcare and clinical studies. The university actively engages in clinical trials to contribute to medical knowledge and improve patient care, leveraging its robust infrastructure and expert faculty. With a commitment to ethical research practices and collaboration with healthcare professionals, Abant Izzet Baysal University aims to enhance the understanding of diseases and develop effective therapeutic interventions, fostering a strong link between academia and clinical application.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bolu, Merkez, Turkey
Patients applied
Trial Officials
Mustafa Fatih Yaşar, MD
Principal Investigator
Bolu Abant Izzet Baylsa University
Ramazan KURUL, Ph.D
Principal Investigator
Bolu Abant Izzet Baylsa University
Muhammed Nur Ögün, MD
Principal Investigator
Bolu Abant Izzet Baylsa University
Şebnem AVCI, Ph.D
Study Director
Bolu Abant Izzet Baylsa University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials